Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ganaxolone in Infantile Spasms
NCT00441896Phase 2Completed
- Sponsor
- Marinus Pharmaceuticals
- Start
- Jan 2007
- Primary completion
- May 2008
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 2 trial of ganaxolone in infantile epileptic spasms syndrome (IESS), sponsored by Marinus Pharmaceuticals. Started Jan 2007; status: completed.
02
Drugs
ganaxolone
03
Conditions
infantile epileptic spasms syndrome (IESS)
Beyond the preview
Go deeper on NCT00441896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00441896.